HomeREGULATORY
REGULATORY

MHLW Orders Label Revisions for Otezla, Ceftriaxone
(Aug.3.2018)

The Ministry of Health, Labor and Welfare (MHLW) issued a notification on August 2 ordering label revisions for Celgene’s psoriasis treatment Otezla (apremilast) and Taiyo Pharma’s Rocephin (ceftriaxone sodium hydrate) and its generics ...
(LOG IN FOR FULL STORY)